Welcome to our dedicated page for Cellebrite DI Ltd. news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite DI Ltd. stock.
Cellebrite DI Ltd. (Nasdaq: CLBT) is an Israeli digital intelligence company renowned for delivering comprehensive tools and solutions to federal, state, and local law enforcement, as well as enterprise companies and service providers. The company’s offerings assist in the collection, review, analysis, and management of digital data.
Core Business: Cellebrite's suite of products includes the UFED series for data extraction from mobile devices, Physical Analyzer for deep digital data analysis, UFED Cloud for cloud data retrieval, Frontliner, Responder, Premium, and Seeker, each designed to serve different aspects of digital investigations.
Recent Achievements and Projects: Recently, Cellebrite has partnered with Coalfire to enable U.S. federal customers to access Cellebrite's SaaS technology. This collaboration is part of Cellebrite's ongoing efforts to achieve FedRAMP authorization, ensuring the highest standards of security and data compliance for its SaaS solutions.
Financial Condition: For the first quarter of 2024, the company reported strong financial performance with expanded business globally and improved profitability. Cellebrite has reaffirmed its optimistic outlook for the remainder of the year, expecting to drive substantial revenue and adjusted EBITDA growth.
Partnerships: Collaborating with cybersecurity leader Coalfire, Cellebrite aims to strengthen its FedRAMP authorization process, reflecting a commitment to robust security standards.
Products and Solutions: Cellebrite’s SaaS-based solutions, like Guardian and Endpoint Inspector SaaS, offer scalable, secure data management and evidence sharing, enhancing operational efficiency and collaboration between investigators. These solutions ensure consent-based data collection, adhering to ethical and legal standards.
Significance: Cellebrite’s mission is to protect and save lives, accelerate justice, and preserve privacy. Their digital investigative solutions empower organizations to master the complexities of legally sanctioned investigations, transforming data collection and analysis processes. Trusted globally, their platform is instrumental in advancing digital investigations for both public and private sectors.
Cellebrite (NASDAQ: CLBT), a leader in Digital Investigative solutions, will report its Q2 2024 financial results on August 15, 2024, before market open. A live conference call and webcast will follow at 8:30 a.m. ET to review the results and discuss the company's outlook for 2024. Investors can access the call via a designated call-in number or through a live webcast. Historical financial data and supplemental information will be available on Cellebrite's investor relations website. A replay and transcript of the call will also be accessible later.
Cellebrite, a leader in digital investigative solutions, announced the availability of its Endpoint Inspector SaaS on the AWS Marketplace. This solution, part of Cellebrite's Case-to-Closure platform, allows corporate investigators and eDiscovery practitioners to collect and analyze data in real-time from various remote devices. Utilizing AWS cloud infrastructure, Endpoint Inspector SaaS enhances data extraction speed and insight depth for corporate investigations, such as fraud and intellectual property theft. It supports hybrid work environments, enabling secure, consent-based data collection without the need for physical device access. AWS Marketplace facilitates easy deployment, automated billing, and payment tracking.
Leopard Asset Management (LAM) is calling on Sun shareholders to hold the company's management accountable for failing to increase shareholder value. LAM has highlighted Sun's undervaluation, primarily due to its significant holdings in Cellebrite (NASDAQ: CLBT), and other liquid assets.
Since LAM's campaign in March 2024, Sun's share price briefly increased by 23% but fell by 19% after a disappointing AGM agenda was released, indicating a lack of trust in management.
LAM urges shareholders to vote against CEO Ryusuke Utsumi and his team in the upcoming June 25 AGM, citing management's failure to take meaningful action to close the valuation gap.
Sun's shares are valued at ¥7,200 based on liquid assets, far above the current market price of ¥3,300, emphasizing the need for a change in leadership to realize the company's true value.
Cellebrite (NASDAQ: CLBT) announced its Q1 2024 results, reporting a 27% year-over-year increase in Annual Recurring Revenue (ARR) to $331.8 million. Q1 2024 revenue rose by 26% to $89.6 million, driven by a 29% growth in subscription revenue. The company recorded a GAAP net loss of $71.4 million and a non-GAAP net income of $16.9 million. Adjusted EBITDA stood at $17.6 million with a 19.7% margin. CEO Yossi Carmil emphasized the global expansion and profitability improvements, noting the positive reception of new products like the Inseyets digital forensics software. The company reaffirmed its outlook for 2024, expecting ARR between $380 million and $400 million, and revenue between $370 million and $380 million for the full year.
Cellebrite (NASDAQ: CLBT), a global leader in digital investigative solutions, announced its participation in several investor conferences from May 26 to June 5, 2024. The company will engage in various formats, including fireside chats, 1x1 meetings, and presentations.
Key dates include May 26 at the Oppenheimer 25th Annual Israeli Conference, May 29 at the Craig-Hallum Institutional Investor Conference, May 30 at the TD Cowen 52nd Annual Technology, Media & Telecom Conference, and June 5 at the William Blair 44th Annual Growth Stock Conference.
Cellebrite executives like Dana Gerner (CFO), Andrew Kramer (VP), and Yossi Carmil (CEO) will present at these events. The conferences are opportunities for the company to highlight its digital investigative solutions and connect with investors.
FAQ
What is the current stock price of Cellebrite DI Ltd. (CLBT)?
What is the market cap of Cellebrite DI Ltd. (CLBT)?
What does Cellebrite DI Ltd. specialize in?
What are some of the key products offered by Cellebrite?
What recent collaboration has Cellebrite engaged in?
What are Cellebrite's financial expectations for 2024?
How does Cellebrite ensure the security of its solutions?
What is Cellebrite's mission?
Who are the typical users of Cellebrite’s products?
What makes Cellebrite’s SaaS solutions unique?
Where can investors find detailed financial information about Cellebrite?
How does Cellebrite contribute to digital investigations?
